Phase 2 OCD Trial, Recruiting NCT04539951 Sponsor: Shanghai Mental Health Center Condition: OCD
Back to Ocd

Phase 2 OCD Trial, Recruiting

NCT04539951
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Obsessive-Compulsive Disorder (OCD) as your main condition, based on standard diagnostic guidelines
  • You are between 18 and 65 years old
  • Your OCD symptoms are rated as at least moderately severe, based on a standard OCD assessment scale called the Y-BOCS
  • You have never taken medication for OCD, and have not had any type of therapy for OCD in the past month
  • You have read and signed a consent form agreeing to take part in the trial

Who may not be able to join:

  • You have been diagnosed with a psychotic disorder (such as schizophrenia) or a bipolar disorder
  • You are considered to have a moderate or higher risk of suicide, based on a standard assessment tool
  • You have had significant problems with alcohol or drug use in the past year that could affect your ability to stick to the treatment
  • You have severe depression, based on a standard questionnaire called the Beck Depression Inventory
  • You have other mental health or physical health conditions that might affect how well the treatment works or your ability to follow the treatment plan, such as borderline personality disorder or nervous system disorders (confirm with trial site)
  • You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Zhen Wang, PhD,MD, Shanghai Mental Health Center

Phone: 862134773516

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Shanghai Mental Health Center
Registry
ClinicalTrials.gov
Start date
22 September 2020
Est. completion
30 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov